Back to Search
Start Over
ADRs following use of oral COVID-19 therapeutics (Paxlovid, Lagevrio) in New Zealand.
- Source :
-
Reactions Weekly . 12/17/2022, Vol. 1937 Issue 1, p1-1. 1p. - Publication Year :
- 2022
-
Abstract
- Paxlovid is an oral COVID-19 therapeutic that has the potential for many drug-drug interactions. An overview of potential drug-drug interactions with Paxlovid was also provided. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 01149954
- Volume :
- 1937
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Reactions Weekly
- Publication Type :
- Periodical
- Accession number :
- 160840736
- Full Text :
- https://doi.org/10.1007/s40278-022-29681-1